UK and EU Annual Life Sciences Conference, Plus U.S. Life Sciences Developments for European Counsel Programme

Arnold & Porter is pleased to invite you to our complimentary 2025 UK and EU Annual Life Sciences Conference – with an optional day two program on critical developments in the U.S. for European counsel -- taking place on 18-19 September.

Day 1 (18 September) will concentrate on pivotal developments and trends relevant to UK and EU life sciences companies.

Topics will include:

• Global trends in market access
• Regulatory update
• How to plan for generic launch
• Developments in the manufacture of advanced therapy medicinal products (ATMPs)
• Use of AI and the medicines lifecycle
• Product liability

Day 1 Agenda

Day 2 (19 September) will build on day one’s EU and UK life science company focus, featuring a half-day morning programme on recent U.S. policy and regulatory changes with significant implications for the global life sciences industry. Topics will consider the current or likely impact to European market dynamics and include:

• Trump 2.0: The U.S. political, policy, and legal environment for European life sciences companies
• Fundamental changes at FDA: Impact on products
• Navigating changes to U.S. government health care programs and drug pricing
• The European impact of Trump administration changes to tariffs, supply chains, and enforcement

Day 2 Agenda

Participation

This two-day programme is a must‑attend for in-house counsel and in-house regulatory professionals in the pharmaceutical, biologics, biotech, and medical device sectors. Benefit from expert insights presented by Arnold & Porter’s leading cross-practice life sciences legal team, and enjoy valuable networking opportunities with your industry peers.

Locations